MyMemory, World's Largest Translation Memory
Click to expand

Language pair: Click to swap content  Subject   
Ask Google

You searched for: stafilokoki    [ Turn off colors ]

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Latvian

English

Info

stafilokoki: nekonstatē 1 g olu produkta,

staphylococci: absence in 1 g of egg product,

Last Update: 2014-10-18
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

Metacilīnrezistenti stafilokoki+ # Izteikti rezistenti mikroorganismi:

Methicillin-resistant staphylococci +# Inherently resistant organisms:

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Meticilīn - rezistenti stafilokoki vienmēr jāuzstver kā rezistents pret doripenēmu.

Methicillin-resistant staphylococci should always be considered as resistant to doripenem.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Tas ir arī efektīvs pret grampozitīviem mikroorganismiem, tādiem kā stafilokoki un streptokoki.

It is also effective against Gram-positive organisms, such as staphylococci and streptococci.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

S ≤1 mg/ l un R > 4 mg/ l Ar sugām nesaistīti Stafilokoki Enterobacteriaceae Acinetobacter sugas

S ≤1 mg/l and R > 4 mg/l inferred from the methicillin breakpoint

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA
Warning: Contains invisible HTML formatting

Pozitīvos MRSA pārbauda uz A tipa stafilokoku (Spa tipizēšana).

Positive MRSA’s shall be tested for Staphylococcus type A (Spa-typing).

Last Update: 2014-11-13
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

EUR 25 par A tipa stafilokoka tipizēšanu (Spa tipizēšana);

EUR 25 per Staphylococcus type A typing (Spa typing);

Last Update: 2014-11-13
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

Kopiena piešķir Francijai finansiālu atbalstu to Regulas (EK) Nr. 882/2004 32. pantā minēto funkciju un pienākumu īstenošanai, kurus attiecībā uz koagulāzes pozitīvo stafilokoku, tostarp Staphylococccus aureus, analīzēm un testiem īstenos Laboratoire d'études et de recherches sur la qualité des aliments et sur les procédés agroalimentaires (LERQAP), Maisons-Alfort, Francijā.

The Community grants financial contribution to France for the functions and duties provided for in Article 32 of Regulation (EC) No 882/2004, to be carried out by the the Laboratoire d'études et de recherches sur la qualité des aliments et sur les procédés agroalimentaires (LERQAP), Maisons-Alfort, France, in respect of analysis and testing of Coagulase positive Staphylococci, including Staphylococccus aureus.

Last Update: 2014-11-05
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

Kopienas references laboratorija koagulāzes pozitīviem stafilokokiem, tostarp staphylococcusaureus:

Community reference laboratory for Coagulase positive Staphylococci, including Staphylococcus aureus:

Last Update: 2014-11-03
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

tā kā daži pielikuma noteikumi attiecībā uz stafilokoku noteikšanu olu produktos un dažu olu produktu glabāšanas temperatūrām jāpielāgo zinātnes un tehnikas attīstībai saskaņā ar Direktīvas 89/437/EEK 10. pantu,

Whereas certain provisions of the Annex should be adapted to scientific and technological progress, in accordance with Article 10 of Directive 89/437/EEC, as regards testing for staphylococci in egg products and the storage temperatures for certain egg products,

Last Update: 2014-10-19
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: DGT-TM

Retāk: kandidoze, stafilokoku infekcijas.

Uncommon: candidiasis, staphylococcal infection.

Last Update: 2013-05-06
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Chlamydia ģintis Mycoplasma ģintis Rickettsia ģintis Legionella ģintis * Aktivitāte pieteiekami pierādīta klīniskajos pētījumos. † INVANZ efektivitāte penicilīnrezistentu Streptococcus pneumoniae izraisītas “ sadzīves ” pneimonijas ārstēšanā nav pierādīta. + Iegūtās rezistences biežums dažās dalībvalstīs > 50%. # Metacilīnrezistentie stafilokoki (tai skaitā MRSA) vienmēr ir rezistenti pret beta laktāmiem.

Chlamydia species Mycoplasma species Rickettsia species Legionella species * Activity has been satisfactorily demonstrated in clinical studies. † The efficacy of INVANZ in the treatment of community acquired pneumonia due to penicillin- resistant Streptococcus pneumoniae has not been established. + frequency of acquired resistance > 50% in some Member States # Methicillin-resistant staphylococci (including MRSA) are always resistant to betalactams.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA
Warning: Contains invisible HTML formatting

Pret metacilīnu rezistenti stafilokoki un enterokoki ir rezistenti pret ertapenēmu, pateicoties penicilīnus saistošajām olbaltumvielām (PBP); P. aeroginosa un citas nefermentatīvas baktērijas parasti ir rezistentas, iespējams, pateicoties limitētai penetrācijai un aktīvai izvadīšanai.

Methicillin-resistant staphylococci and enterococci are resistant to ertapenem, owing to PBP target insensitivity; P. aeruginosa and other non-fermentative bacteria are generally resistant, probably owing to limited penetration and to active efflux.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Implantāta infekcija, stafilokoku infekcija Hematoma Perifērā tūska

Graft infection, Staphylococcal infection Haematoma Oedema peripheral

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Tas var izraisīt tādas komplikācijas kā cellulītu, rozi vai iespējami letālu stafilokoku izraisītu applaucētas ādas sindromu (Staphylococcal scalded skin syndrome) vai sepsi.

21 Skin lesions induced by cetuximab may predispose patients to superinfections (e. g. with S. aureus), which may lead to subsequent complications, e. g. cellulitis, erysipelas, or, potentially with fatal outcome, staphylococcal scalded skin syndrome or sepsis.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Organismi ar pārmantotu rezistenci Gram pozitīvi aerobi mikroorganismi Enterococcus faecium Gram negatīvi aerobi mikroorganismi Stenotrophomonas maltophila Legionella sugas * Sugas, pret kurām aktivitāte ir pierādīta klīniskajos pētījumos. $Sugas, kam dabīgi piemīt vidējs jutīgums. + Sugas ar > 50% iegūto rezistenci vienā vai vairākās dalībvalstīs. ^Visus pret meticilīnu rezistentos stafilokokus jāuzskata par rezistentiem pret doripenēmu.

Gram Positive Aerobes Enterococcus faecium Gram Negative Aerobes Stenotrophomonas maltophilia Legionella spp. * species against which activity has been demonstrated in clinical studies $species that show natural intermediate susceptibility + species with > 50% acquired resistance in one or more Member State ^all methicillin-resistant staphylococci should be regarded as resistant to doripenem

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA
Warning: Contains invisible HTML formatting

kandidoze, stafilokoku infekcija pietvīkums/ karstuma viļņi astēnija/ nogurums

candidiasis, staphylococcal infection flushing/ hot flush asthaenia/ fatigue

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Ilgstošas vai atkārtotas Staphylococcus aureus infekcijas dēļ ārstēšana bija nesekmīga 19/ 120 (15, 8%) pacientiem Cubicin grupā, 9/ 53 (16, 7%) pacientiem vankomicīna grupā un 2/ 62 (3, 2%) pacientiem grupā, kurā pacienti tika ārstēti ar anti- stafilokoku pussintētiskā penicilīna preparātiem.

Failure of treatment due to persisting or relapsing Staphylococcus aureus infections was observed in 19/ 120 (15.8%) patients treated with Cubicin, 9/ 53 (16.7%) patients treated with vancomycin and 2/ 62 (3.2%) patients treated with an anti-staphylococcal semi-synthetic penicillin.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Parasti jutīgas sugas Staphylococcus aureus * Staphylococcus haemolyticus Koagulāzes negatīvie stafilokoki Streptococcus agalactiae * Streptococcus dysgalactiae equisimilis apakšsuga * Streptococcus pyogenes * G grupas streptokoki Clostridium perfringens Peptostreptococcus spp Iedzimti rezistenti mikroorganismi Gramnegatīvi mikroorganismi * atzīmētas sugas, pret kurām uzskata, ka klīniskos pētījumos aktivitāte ir pietiekami pierādīta.

Commonly Susceptible Species Staphylococcus aureus * Staphylococcus haemolyticus Coagulase negative staphylococci Streptococcus agalactiae* Streptococcus dysgalactiae subsp equisimilis* Streptococcus pyogenes* Group G streptococci Clostridium perfringens Peptostreptococcus spp Inherently resistant organisms Gram negative organisms * denotes species against which it is considered that activity has been satisfactorily demonstrated in clinical studies.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA

Robežkoncentrācijas Eiropas pretmikrobu jutības testēšanas komiteja (EUCAST) ir noteikusi, ka minimālās inhibējošas koncentrācijas (MIK) attiecībā pret stafilokoku un streptokoku grupas mikroorganismiem (izņemot S. pneumoniae) ir ≤ 1 mg/ l jutīgiem organismiem un > 1 mg/ l nejutīgiem organismiem.

Breakpoints Minimum inhibitory concentration (MIC) breakpoint established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for Staphylococci and Streptococci (except S. pneumoniae) are Susceptible ≤ 1 mg/ l and Resistant > 1 mg/ l.

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: EMEA
Warning: Contains invisible HTML formatting

Add a translation